Literature DB >> 26369510

Movement disorders: Repurposing riluzole to treat hereditary cerebellar ataxia.

Heather Wood.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26369510     DOI： 10.1038/nrneurol.2015.161

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  1 in total

1.  Riluzole in patients with hereditary cerebellar ataxia: a randomised, double-blind, placebo-controlled trial.

Authors:  Silvia Romano; Giulia Coarelli; Christian Marcotulli; Luca Leonardi; Francesca Piccolo; Maria Spadaro; Marina Frontali; Michela Ferraldeschi; Maria Chiara Vulpiani; Federica Ponzelli; Marco Salvetti; Francesco Orzi; Antonio Petrucci; Nicola Vanacore; Carlo Casali; Giovanni Ristori
Journal:  Lancet Neurol       Date:  2015-08-25       Impact factor: 44.182
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.